p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas

Cancer Research

Volumn 61, Issue 7, 2001, Pages 3157-3163

  Divan, Ayesha ^a   Lawry, John ^a   Dunsmore, Ian R ^a   Parsons, M Andrew ^a   Royds, Janice A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA BINDING PROTEIN 1; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TUMOR MARKER; GROWTH FACTOR; OXYGEN; PROTEIN P21;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; EXON; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE; VASCULARIZATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL LINE;

APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; EXONS; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035297542     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Apoptosis related genes in retinoblastomas
2. Significance of retinoma and ptosis bulbi for retinoblastoma
3. Mutation and cancer: Statistical study of retinoblastoma
4. Deletion of a DNA sequence in retinoblastomas and mesenchymal tumours: Organisation of the sequence and its encoded protein
5. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
6. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
7. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells
8. Requirement for a functional Rb1 gene in murine development
9. Effects of an Rb mutation in the mouse
10. Mice deficient for pRb are non-viable and show defects in neurogenesis and haematopoiesis
11. p53-dependent apoptosis produced by Rb deficiency in the developing mouse lens
12. pRb controls proliferation, differentiation and cell death of skeletal muscle cells and other lineages during embryogenesis
13. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice
14. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
15. Altered cell cycle regulation in the lens of HPV-16 E6 and E7 transgenic mice: Implications for tumour suppressor gene function in development
16. Adenovirus E1B, 19Kda protein overcomes the cytotoxicity of E1A proteins
17. The adenovirus E1A proteins induce apoptosis which is inhibited by E1B 19Kda and Bcl-2 proteins
18. Stabilisation of the p53 tumour suppressor is induced by adenovirus E1A and is accompanied by apoptosis
19. Wildtype p53 mediates apoptosis by E1A, which is inhibited by E1B
20. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein
21. Induction of p21 (WAF-1/CIP1) during differentiation
22. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage
23. Transcriptional activation of Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic line U937
24. Suppression of cancer cell growth by adenovirus expressing p21 (WAF-1) deficient in PCNA interaction
25. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene mediated apoptosis
26. New functional activities for the p21 family of CDK inhibitors
27. Immediate early upregulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways
28. The insulin-like growth factor 1 receptor as a physiologically relevant target of p53 in apoptosis by interleukin-3 withdrawal
29. Wild-type p53 negatively regulates the expression of a microtubule associated protein
30. Induction of the growth inhibitor IGF-binding protein 3 by p53
31. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
32. p107 is a suppressor of retinoblastoma development in pRb-deficient mice
33. Similar chromosomal abnormalities in several retinoblastomas
34. Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: Verification by standard staining techniques, new densitometric methods and somatic cell hybridisation
35. Developmental basis of retinal-specific induction of cancer by RB mutation
36. Database of p53 gene somatic mutations in human tumours and cell lines
37. The significance of apoptosis
38. Cell and environment interactions in tumour microregions: The multicell spheroid model
39. The unique physiology of solid tumours-opportunities and problems for cancer research
40. Differential regulation of p21 by p53 and pRb in cellular responses to oxidative stress
41. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression
42. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
43. Deregulated transcription factor E2F expression leads to S-phase entry and p53-mediated apoptosis
44. p53 and E2F-1 co-operate to mediate apoptosis
45. Established cell lines transformed by E2F-1 overexpression contain wild type p53
46. Distinct roles for E2F proteins in cell growth and apoptosis
47. Functional and physical interaction of the ARF tumour suppressor with p53 and Mdm-2
48. The INK4A tumour suppressor gene product p19ARF interacts with Mdm-2 and neutralises MDM2's inhibition of p53
49. ARF promotes MDM2 degradation and stabilises p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumour suppressor pathways
50. Mdm-2 promotes the rapid degradation of p53
51. Regulation of p53 stability by Mdm-2
52. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions
53. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development